Related Experiment Video
Updated: May 17, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Ischaemic cardiogenic shock. Where do we stand in 2012?]
1Service de cardiologie et maladies vasculaires, CHU de Rennes, 35000 Rennes, France. guillaume.leurent@chu-rennes.fr
Cardiogenic shock (CS) following myocardial infarction remains a significant challenge with high mortality. This review covers CS epidemiology, pathophysiology, and treatment options like coronary revascularization and ventricular assistance.
Area of Science:
- Cardiology
- Critical Care Medicine
Context:
- Cardiogenic shock (CS) complicates approximately 5% of acute myocardial infarctions.
- CS presents a significant therapeutic challenge with a nearly 45% mortality rate.
- Immediate post-myocardial infarction CS requires urgent and effective management strategies.
Purpose:
- To review the current epidemiological data of cardiogenic shock.
- To elucidate the complex pathophysiology of cardiogenic shock.
- To detail treatment modalities for interventional cardiologists, focusing on coronary revascularization and percutaneous left ventricular assistance.
Summary:
- This review synthesizes current knowledge on cardiogenic shock (CS), a critical complication of myocardial infarction.
- It examines CS epidemiology, underlying pathophysiology, and therapeutic interventions.
- Key treatments discussed include coronary revascularization and percutaneous left ventricular assistance devices such as intra-aortic balloon pumps.
Impact:
- Provides interventional cardiologists with a comprehensive overview of cardiogenic shock management.
- Highlights the importance of timely revascularization and mechanical circulatory support.
- Aims to improve outcomes for patients experiencing cardiogenic shock post-myocardial infarction.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Introduction Cardiac Emergencies
Acute Coronary Syndrome IV: Interprofessional Care
